Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
covid-19
3
×
deals
fda
3
×
life sciences
national blog main
startups
3
×
amag pharmaceuticals
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
investing
ipo
national
national top stories
new york blog main
new york top stories
oric pharmaceuticals
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
What
bio
ipo
roundup
acquisitions
alliance
announced
biotech
bristol
buy
calls
ceo
changing
collabs
color
company
covid
crispr
daniel
days
deal
debut
developing
gilead
gilead’s
growing
help
hours
introduce
kudos
late
leaves
lyra
markets
medicines
million
month
myers’s
new
nose
noses
Language
unset
Current search:
covid-19
×
fda
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More